GlaxoSmithKline Pharmaceuticals reports 30% fall in Q2 net profit

08 Aug 2013 Evaluate

GlaxoSmithKline Pharmaceuticals has reported results for second quarter ended June 30, 2013.

On standalone basis, the company has reported a fall of 29.65% in its net profit at Rs 115.04 crore for the quarter, as compared to Rs 163.52 crore for the same quarter in the previous year.  Total income of the company has decreased by 2.52% to Rs 682.22 crore for the quarter under review as compared to Rs 699.88 crore for the quarter ended June 30, 2012.

GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.

Glaxosmithkline Phar Share Price

2392.95 23.10 (0.97%)
14-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1700.55
Dr. Reddys Lab 1186.45
Cipla 1434.60
Zydus Lifesciences 884.00
Lupin 2195.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×